Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening
about
Second trimester serum tests for Down's Syndrome screeningUrine tests for Down's syndrome screeningFirst trimester serum tests for Down's syndrome screeningAssisted reproduction: the epigenetic perspective.First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.Cell-free fetal DNA levels in pregnancies conceived by IVF.Discordant non-invasive prenatal testing (NIPT) - a systematic review.Maternal plasma DNA testing for aneuploidy in pregnancies achieved by assisted reproductive technologies.Two- and three-dimensional ultrasound in malformations of the medullary canal: report of four cases.Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.Are serum markers altered in first trimester screening in poor ovarian reserve patients?Controlled ovarian hyperstimulation leads to high progesterone and estradiol levels during early pregnancy.Maternal age and serum concentration of human chorionic gonadotropin in early pregnancy.Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception.Noninvasive prenatal testing (NIPT) in twin pregnancies with treatment of assisted reproductive techniques (ART) in a single center.Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome.First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI.First-trimester serum marker distribution in singleton pregnancies conceived with assisted reproduction.First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study
P2860
Q22252964-E3F7A36A-4CA9-4551-ABEB-A6D86701DBAAQ24186912-80830129-F5B9-4D8E-B03B-32E352B4EF10Q24187589-13D9AAF7-4626-4531-B9CD-457DC7CD707AQ36182585-49443B81-EB4E-4EA0-9429-AF7DA589B25CQ36308489-DAEA6A60-F99E-4EA8-9407-F770C35494EEQ36308492-4FC8437C-7F07-4FF7-99A2-0B38BEA215D9Q38442016-5270E4C8-989E-4E43-998D-AC2B43754A8CQ39223783-946F6DAF-540E-4B37-9960-CB057023FD83Q43524466-626965EA-6CC3-44CC-BD1C-A2E4025F7177Q43728369-7D64F5D5-2923-4B33-85C5-E198EEEBEC75Q46405115-5862AECC-752E-4940-A858-160D6152B6C6Q46613650-2C348DC1-7EE9-4D61-B0B2-0BD861B2639BQ48594730-D05EA362-C0D3-4C43-99A4-3FAF7D85DF37Q50643007-9695194E-753C-4C5B-82DF-70071CA64B27Q50643190-556EAF2D-841B-439D-9C40-5E91B182C17FQ51343352-69284D56-DCB1-43F4-83D3-2633224A4DC0Q51796854-CDE5B5C8-4FD0-401C-8D65-5FA05424A923Q51858577-8D6CAB8C-3BF9-4A99-8B03-F6808282F596Q53065490-C2AF87AA-F572-4762-A448-2F05E1A10C78Q57285237-1086D2D7-BFFA-4586-A637-D2897E5A2A5B
P2860
Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening
description
scientific article published on 01 December 1999
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 1999
@uk
name
Serum markers for Down's syndr ...... ations for antenatal screening
@en
Serum markers for Down's syndr ...... ations for antenatal screening
@nl
type
label
Serum markers for Down's syndr ...... ations for antenatal screening
@en
Serum markers for Down's syndr ...... ations for antenatal screening
@nl
prefLabel
Serum markers for Down's syndr ...... ations for antenatal screening
@en
Serum markers for Down's syndr ...... ations for antenatal screening
@nl
P2093
P1476
Serum markers for Down's syndr ...... ations for antenatal screening
@en
P2093
P304
P356
10.1111/J.1471-0528.1999.TB08186.X
P577
1999-12-01T00:00:00Z